103 related articles for article (PubMed ID: 20707217)
1. [Apoptosis induced by bleomycin: influence of cellular models].
Brahim-Loghmari S; Kenani A
Arch Inst Pasteur Tunis; 2009; 86(1-4):15-25. PubMed ID: 20707217
[TBL] [Abstract][Full Text] [Related]
2. Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma.
Alas S; Ng CP; Bonavida B
Clin Cancer Res; 2002 Mar; 8(3):836-45. PubMed ID: 11895917
[TBL] [Abstract][Full Text] [Related]
3. Loss of drug-induced activation of the CD95 apoptotic pathway in a cisplatin-resistant testicular germ cell tumor cell line.
Spierings DC; de Vries EG; Vellenga E; de Jong S
Cell Death Differ; 2003 Jul; 10(7):808-22. PubMed ID: 12815464
[TBL] [Abstract][Full Text] [Related]
4. Deglycosylated bleomycin induces apoptosis in lymphoma cell via c-jun NH2-terminal kinase but not reactive oxygen species.
Souhir B; Laurent P; Sonia Y; Delphine M; Marion C; Cédric R; Olivier M; Abderraouf K; Ali B
Biochem Pharmacol; 2007 Nov; 74(10):1445-55. PubMed ID: 17825263
[TBL] [Abstract][Full Text] [Related]
5. Caspase-mediated activation of a 36-kDa myelin basic protein kinase during anticancer drug-induced apoptosis.
Kakeya H; Onose R; Osada H
Cancer Res; 1998 Nov; 58(21):4888-94. PubMed ID: 9809995
[TBL] [Abstract][Full Text] [Related]
6. Histone H1.2 is translocated to mitochondria and associates with Bak in bleomycin-induced apoptotic cells.
Okamura H; Yoshida K; Amorim BR; Haneji T
J Cell Biochem; 2008 Apr; 103(5):1488-96. PubMed ID: 17879944
[TBL] [Abstract][Full Text] [Related]
7. Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention.
Jazirehi AR; Bonavida B
Oncogene; 2005 Mar; 24(13):2121-43. PubMed ID: 15789036
[TBL] [Abstract][Full Text] [Related]
8. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
Sylvester PW; Shah S
Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643
[TBL] [Abstract][Full Text] [Related]
9. [The role of mitogen-activated protein kinase (MAPK) pathway in the action mechanism of PYM-induced KB cells apoptosis].
Dai G; Zhang Z; Zhou M; Yu S
Zhonghua Kou Qiang Yi Xue Za Zhi; 2002 Mar; 37(2):97-8. PubMed ID: 12475417
[TBL] [Abstract][Full Text] [Related]
10. alpha-TEA inhibits survival and enhances death pathways in cisplatin sensitive and resistant human ovarian cancer cells.
Yu W; Shun MC; Anderson K; Chen H; Sanders BG; Kline K
Apoptosis; 2006 Oct; 11(10):1813-23. PubMed ID: 16850165
[TBL] [Abstract][Full Text] [Related]
11. Re-evaluation of tumor-specific cytotoxicity of mitomycin C, bleomycin and peplomycin.
Sasaki M; Okamura M; Ideo A; Shimada J; Suzuki F; Ishihara M; Kikuchi H; Kanda Y; Kunii S; Sakagami H
Anticancer Res; 2006; 26(5A):3373-80. PubMed ID: 17094455
[TBL] [Abstract][Full Text] [Related]
12. Silibinin modulates UVB-induced apoptosis via mitochondrial proteins, caspases activation, and mitogen-activated protein kinase signaling in human epidermoid carcinoma A431 cells.
Mohan S; Dhanalakshmi S; Mallikarjuna GU; Singh RP; Agarwal R
Biochem Biophys Res Commun; 2004 Jul; 320(1):183-9. PubMed ID: 15207719
[TBL] [Abstract][Full Text] [Related]
13. The chemoprotective agent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway.
Wu YJ; Muldoon LL; Neuwelt EA
J Pharmacol Exp Ther; 2005 Feb; 312(2):424-31. PubMed ID: 15496615
[TBL] [Abstract][Full Text] [Related]
14. Time-dependent apoptosis of alveolar macrophages from rats exposed to bleomycin: involvement of tnf receptor 2.
Zhao HW; Hu SY; Barger MW; Ma JK; Castranova V; Ma JY
J Toxicol Environ Health A; 2004 Sep; 67(17):1391-406. PubMed ID: 15371238
[TBL] [Abstract][Full Text] [Related]
15. A common pathway for chemotherapy-induced apoptosis in human squamous cell carcinoma lines distinct from that of receptor-mediated cell death.
Crowe DL; Yoon E
Anticancer Res; 2003; 23(3B):2321-8. PubMed ID: 12894510
[TBL] [Abstract][Full Text] [Related]
16. The differential sensitivity of Bc1-2-overexpressing human breast tumor cells to TRAIL or doxorubicin-induced apoptosis is dependent on Bc1-2 protein levels.
Ruiz de Almodóvar C; Ruiz-Ruiz C; Muñoz-Pinedo C; Robledo G; López-Rivas A
Oncogene; 2001 Oct; 20(48):7128-33. PubMed ID: 11704839
[TBL] [Abstract][Full Text] [Related]
17. Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis.
Fulda S; Meyer E; Friesen C; Susin SA; Kroemer G; Debatin KM
Oncogene; 2001 Mar; 20(9):1063-75. PubMed ID: 11314043
[TBL] [Abstract][Full Text] [Related]
18. Conversion of CD95 (Fas) Type II into Type I signaling by sub-lethal doses of cycloheximide.
Brumatti G; Yon M; Castro FA; Bueno-da-Silva AE; Jacysyn JF; Brunner T; Amarante-Mendes GP
Exp Cell Res; 2008 Feb; 314(3):554-63. PubMed ID: 18078929
[TBL] [Abstract][Full Text] [Related]
19. Signal transduction of p53-independent apoptotic pathway induced by hexavalent chromium in U937 cells.
Hayashi Y; Kondo T; Zhao QL; Ogawa R; Cui ZG; Feril LB; Teranishi H; Kasuya M
Toxicol Appl Pharmacol; 2004 Jun; 197(2):96-106. PubMed ID: 15163545
[TBL] [Abstract][Full Text] [Related]
20. Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231.
Aroui S; Brahim S; De Waard M; Bréard J; Kenani A
Cancer Lett; 2009 Nov; 285(1):28-38. PubMed ID: 19523755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
